Array-Based FMR1 Sequencing and Deletion Analysis in Patients with a Fragile X Syndrome-Like Phenotype

被引:22
作者
Collins, Stephen C. [1 ]
Coffee, Brad [1 ]
Benke, Paul J. [2 ]
Berry-Kravis, Elizabeth [3 ,4 ]
Gilbert, Fred [5 ]
Oostra, Ben [6 ]
Halley, Dicky [6 ]
Zwick, Michael E. [1 ]
Cutler, David J. [1 ]
Warren, Stephen T. [1 ,7 ,8 ]
机构
[1] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA
[2] Joe DiMaggio Childrens Hosp, Hollywood, FL USA
[3] Rush Univ, Med Ctr, Dept Pediat, Chicago, IL 60612 USA
[4] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA
[5] Weill Cornell Med Coll, Dept Pediat, New York, NY USA
[6] Erasmus Univ, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands
[7] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA
[8] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA
关键词
MENTAL-RETARDATION; POINT MUTATION; GENE; REGION;
D O I
10.1371/journal.pone.0009476
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Fragile X syndrome (FXS) is caused by loss of function mutations in the FMR1 gene. Trinucleotide CGG-repeat expansions, resulting in FMR1 gene silencing, are the most common mutations observed at this locus. Even though the repeat expansion mutation is a functional null mutation, few conventional mutations have been identified at this locus, largely due to the clinical laboratory focus on the repeat tract. Methodology/Principal Findings: To more thoroughly evaluate the frequency of conventional mutations in FXS-like patients, we used an array-based method to sequence FMR1 in 51 unrelated males exhibiting several features characteristic of FXS but with normal CGG-repeat tracts of FMR1. One patient was identified with a deletion in FMR1, but none of the patients were found to have other conventional mutations. Conclusions/Significance: These data suggest that missense mutations in FMR1 are not a common cause of the FXS phenotype in patients who have normal-length CGG-repeat tracts. However, screening for small deletions of FMR1 may be of clinically utility.
引用
收藏
页数:4
相关论文
共 23 条
[1]  
Castellví-Bel S, 1999, AM J MED GENET, V84, P262, DOI 10.1002/(SICI)1096-8628(19990528)84:3<262::AID-AJMG18>3.0.CO
[2]  
2-V
[3]   The story of Rett syndrome: From clinic to neurobiology [J].
Chahrour, Maria ;
Zoghbi, Huda Y. .
NEURON, 2007, 56 (03) :422-437
[4]   NO APPARENT INVOLVEMENT OF THE FMR1 GENE IN 5 PATIENTS WITH PHENOTYPIC MANIFESTATIONS OF THE FRAGILE-X-SYNDROME [J].
CHIURAZZI, P ;
DEGRAAFF, E ;
NG, J ;
VERKERK, AJMH ;
WOLFSON, S ;
FISCH, GS ;
KOZAK, L ;
NERI, G ;
OOSTRA, BA .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1994, 51 (04) :309-314
[5]   Mosaic FMR1 deletion causes fragile X syndrome and can lead to molecular misdiagnosis:: A case report and review of the literature [J].
Coffee, Bradford ;
Ikeda, Morna ;
Budimirovic, Dejan B. ;
Hjelm, Lawrence N. ;
Kaufmann, Walter E. ;
Warren, Stephen T. .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2008, 146A (10) :1358-1367
[6]   High-throughput variation detection and genotyping using microarrays [J].
Cutler, DJ ;
Zwick, ME ;
Carrasquillo, MM ;
Yohn, CT ;
Tobin, KP ;
Kashuk, C ;
Mathews, DJ ;
Shah, NA ;
Eichler, EE ;
Warrington, JA ;
Chakravarti, A .
GENOME RESEARCH, 2001, 11 (11) :1913-1925
[7]   A POINT MUTATION IN THE FMR-1 GENE ASSOCIATED WITH FRAGILE-X MENTAL-RETARDATION [J].
DEBOULLE, K ;
VERKERK, AJMH ;
REYNIERS, E ;
VITS, L ;
HENDRICKX, J ;
VANROY, B ;
VANDENBOS, F ;
DEGRAAFF, E ;
OOSTRA, BA ;
WILLEMS, PJ .
NATURE GENETICS, 1993, 3 (01) :31-35
[8]  
DEGRAAFF E, 1995, HUM MOL GENET, V4, P45
[9]   Fragile X syndrome [J].
Garber, Kathryn B. ;
Visootsak, Jeannie ;
Warren, Stephen T. .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2008, 16 (06) :666-672
[10]   FRAGILE-X SYNDROME WITHOUT CCG AMPLIFICATION HAS AN FMR1 DELETION [J].
GEDEON, AK ;
BAKER, E ;
ROBINSON, H ;
PARTINGTON, MW ;
GROSS, B ;
MANCA, A ;
KORN, B ;
POUSTKA, A ;
YU, S ;
SUTHERLAND, GR ;
MULLEY, JC .
NATURE GENETICS, 1992, 1 (05) :341-344